Expression, regulation and function of human metallothioneins in endothelial cells

Journal of Vascular Research

Volumn 51, Issue 3, 2014, Pages 231-238

  Schulkens, Iris A ^a   Castricum, Kitty C M ^a   Weijers, Ester M ^b   Koolwijk, Pieter ^b   Griffioen, Arjan W ^a   Thijssen, Victor L ^a  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^b Institute for Cardiovascular Research   (Netherlands)

Author keywords

Angiogenesis; Endothelial cells; Metallothionein; Quantitative PCR

Indexed keywords

COPPER; MESSENGER RNA; METALLOTHIONEIN; METALLOTHIONEIN 1E; METALLOTHIONEIN 1M; METALLOTHIONEIN 1X; METALLOTHIONEIN II; METALLOTHIONEIN III; SMALL INTERFERING RNA; UNCLASSIFIED DRUG; ZINC;

ANGIOGENESIS; ARTICLE; CELL ACTIVATION; CELL MIGRATION; CELL PROLIFERATION; CELL SPROUTING; CELLULAR, SUBCELLULAR AND MOLECULAR BIOLOGICAL PHENOMENA AND FUNCTIONS; CONTROLLED STUDY; EXPOSURE; GENE EXPRESSION PROFILING; GENE SILENCING; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; REGULATORY MECHANISM; SERUM; UMBILICAL VEIN ENDOTHELIAL CELL; ENDOTHELIUM CELL; HYPOXIA; UMBILICAL VEIN;

CELL MOVEMENT; COPPER; ENDOTHELIAL CELLS; GENE EXPRESSION REGULATION; HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS; HUMANS; METALLOTHIONEIN; PROTEIN ISOFORMS; RNA, MESSENGER; ZINC;

EID: 84906032382     PISSN: 10181172     EISSN: 14230135     Source Type: Journal    
DOI: 10.1159/000365550     Document Type: Article

References (30)

1. Cherian MG, Jayasurya A, Bay BH: Metallothioneinsin human tumors and potentialroles in carcinogenesis. Mutat Res 2003; 533:201-209.
2. Takahashi S: Molecular functions of metallothioneinand its role in hematological malignancies. J Hematol Oncol 2012; 5: 41.
3. Coyle P, Philcox JC, Carey LC, Rofe AM:Metallothionein: the multipurpose protein. Cell Mol Life Sci 2002; 59: 627-647.
4. Kelly EJ, Quaife CJ, Froelick GJ, Palmiter RD:Metallothionein I and II protect against zincdeficiency and zinc toxicity in mice. J Nutr1996; 126: 1782-1790.
5. Masters BA, Kelly EJ, Quaife CJ, Brinster RL,Palmiter RD: Targeted disruption of metallothioneinI and II genes increases sensitivity tocadmium. Proc Natl Acad Sci USA 1994; 91:584-588.
6. Michalska AE, Choo KH: Targeting andgerm-line transmission of a null mutation atthe metallothionein I and II loci in mouse. Proc Natl Acad Sci USA 1993; 90: 8088-8092.
7. Xue W, Liu Q, Cai L, Wang Z, Feng W: Stableoverexpression of human metallothionein-IIa in a heart-derived cell line confers oxidativeprotection. Toxicol Lett 2009; 188: 70-76.
8. Miyashita H, Sato Y: Metallothionein 1 is adownstream target of vascular endothelialzinc finger 1 (VEZF1) in endothelial cells andparticipates in the regulation of angiogenesis. Endothelium 2005; 12: 163-170.
9. Zbinden S, Wang J, Adenika R, Schmidt M,Tilan JU, Najafi AH, Peng X, Lassance-SoaresRM, Iantorno M, Morsli H, Gercenshtein L,Jang GJ, Epstein SE, Burnett MS: Metallothioneinenhances angiogenesis and arteriogenesisby modulating smooth muscle cell andmacrophage function. Arterioscler ThrombVasc Biol 2010; 30: 477-482.
10. Xue W, Liu Y, Zhao J, Cai L, Li X, Feng W:Activation of HIF-1 by metallothionein contributesto cardiac protection in the diabeticheart. Am J Physiol Heart Circ Physiol 2012;302:H2528-H2535.
11. Caperna TJ, Failla ML: Cadmium metabolismby rat liver endothelial and Kupffer cells. BiochemJ 1984; 221: 631-636.
12. McKim JM Jr, Liu J, Liu YP, Klaassen CD: Inductionof metallothionein by cadmiummetallothioneinin rat liver: a proposed mechanism. Toxicol Appl Pharmacol 1992; 112:318-323.
13. Thijssen VL, Hulsmans S, Griffioen AW: Thegalectin profile of the endothelium: alteredexpression and localization in activated andtumor endothelial cells. Am J Pathol 2008;172: 545-553.
14. Van Hinsbergh VW, Sprengers ED, KooistraT: Effect of thrombin on the production ofplasminogen activators and PA inhibitor-1 byhuman foreskin microvascular endothelialcells. Thromb Haemost 1987; 57: 148-153.
15. Ades EW, Candal FJ, Swerlick RA, GeorgeVG, Summers S, Bosse DC, Lawley TJ:HMEC-1: Establishment of an immortalizedhuman microvascular endothelial cell line. JInvest Dermatol 1992; 99: 683-690.
16. Weijers EM, Van Den Broek LJ, Waaijman T,Van Hinsbergh VW, Gibbs S, Koolwijk P: Theinfluence of hypoxia and fibrinogen variantson the expansion and differentiation of adiposetissue-derived mesenchymal stem cells. Tissue Eng Part A 2011; 17: 2675-2685.
17. Thijssen VL, Brandwijk RJ, Dings RP, GriffioenAW: Angiogenesis gene expression profilingin xenograft models to study cellular interactions. Exp Cell Res 2004; 299: 286-293.
18. Dingemans AM, van den Boogaart V, VosseBA, van Suylen RJ, Griffioen AW, ThijssenVL: Integrin expression profiling identifiesintegrin alpha5 and beta1 as prognostic factorsin early stage non-small cell lung cancer. Mol Cancer 2010; 9: 152.
19. Albrecht EA, Dhanasekaran SM, Tomlins S:Immediate early inflammatory gene responsesof human umbilical vein endothelial cells tohemorrhagic venom. Inflamm Res 2011; 60:213-217.
20. Chen J, Jin TY: Influence of isoflavones oncadmium-induced adverse effects in vascularendothelial cells (ECV 304). Biomed EnvironSci 2005; 18: 146-152.
21. Thirumoorthy N, Shyam Sunder A, ManisenthilKumar K, Senthil Kumar M, GaneshG, Chatterjee M: A review of metallothioneinisoforms and their role in pathophysiology. World J Surg Oncol 2011; 9: 54.
22. Hidalgo J, Garcia A, Oliva AM, Giralt M, GasullT, Gonzalez B, Milnerowicz H, Wood A,Bremner I: Effect of zinc, copper and glucocorticoidson metallothionein levels of culturedneurons and astrocytes from rat brain. Chem Biol Interact 1994; 93: 197-219.
23. Bobilya DJ, Reynolds JT, Faia KL, Briske-AndersonM, Reeves PG: Zinc-related metallothioneinmetabolism in bovine pulmonary arteryendothelial cells. J Nutr Biochem 1999;10: 139-145.
24. Joshi B, Ordonez-Ercan D, Dasgupta P, ChellappanS: Induction of human metallothionein1G promoter by VEGF and heavy metals:differential involvement of E2F and metaltranscription factors. Oncogene 2005; 24:2204-2217.
25. Ghoshal K, Majumder S, Li Z, Bray TM, JacobST: Transcriptional induction of metallothionein-I and-II genes in the livers of Cu,Znsuperoxidedismutase knockout mice. BiochemBiophys Res Commun 1999; 264: 735-742.
26. Kojima I, Tanaka T, Inagi R, Nishi H, AburataniH, Kato H, Miyata T, Fujita T, NangakuM: Metallothionein is upregulated by hypoxiaand stabilizes hypoxia-inducible factor in thekidney. Kidney Int 2009; 75: 268-277.
27. Murphy BJ, Kimura T, Sato BG, Shi Y, AndrewsGK: Metallothionein induction by hypoxiainvolves cooperative interactions betweenmetal-responsive transcription factor-1and hypoxia-inducible transcription factor-1alpha. Mol Cancer Res 2008; 6: 483-490.
28. Kim HG, Hwang YP, Jeong HG: Metallothionein-III induces HIF-1alpha-mediated VEGFexpression in brain endothelial cells. BiochemBiophys Res Commun 2008; 369: 666-671.
29. Kim HG, Kim JY, Han EH, Hwang YP, ChoiJH, Park BH, Jeong HG: Metallothionein-2aoverexpression increases the expression ofmatrix metalloproteinase-9 and invasion ofbreast cancer cells. FEBS Lett 2011; 585: 421-428.
30. Chen Q, Jin M, Yang F, Zhu J, Xiao Q, ZhangL: Matrix metalloproteinases: inflammatoryregulators of cell behaviors in vascular formationand remodeling. Mediators Inflamm2013; 2013: 928315.